Epigenetic regulation and post-translational modifications of ferroptosis-related factors in cardiovascular diseases

Chunlu Jing1,2,3, Yupeng Wu4, Yuzhu Zhang1,2

  • 1Department of Ultrasound, The People's Hospital of China Medical University, The People's Hospital of Liaoning Province, 33 Wenyi Road, Shenhe District, Shenyang, 110067, People's Republic of China.

Clinical Epigenetics
|January 11, 2025
PubMed

Insights

Ferroptosis, an iron-dependent cell death, is implicated in cardiovascular diseases (CVDs). This review details how epigenetic regulation of ferroptosis-related factors in cardiomyocytes contributes to CVD progression.

Area of Science:

  • Cardiovascular Biology
  • Cell Death Mechanisms
  • Epigenetics

Background:

  • Iron is vital for human physiology and involved in numerous biochemical reactions.
  • Ferroptosis, a form of iron-dependent regulated cell death, plays a role in various disease pathologies.
  • Iron stability in cardiomyocytes is critical for normal cardiac function, and ferroptosis is observed in multiple cardiovascular diseases (CVDs).

Purpose of the Study:

  • To review the core mechanisms of ferroptosis in cardiomyocytes.
  • To focus on the role of epigenetic regulation and expression of ferroptosis-related factors in CVDs.
  • To provide new insights into CVD pathogenesis and inspire targeted clinical interventions.

Main Methods:

  • Literature review of ferroptosis mechanisms in cardiovascular disease.
  • Analysis of epigenetic regulation's role in ferroptosis-related factors.
  • Synthesis of current understanding of ferroptosis in common cardiovascular diseases.

Main Results:

  • Ferroptosis is a significant factor in the pathogenesis of cardiovascular diseases.
  • Epigenetic modifications and post-translational modifications influence ferroptosis-related factors in cardiomyocytes.
  • Iron homeostasis in cardiomyocytes is regulated by these mechanisms and impacts CVD progression.

Conclusions:

  • A detailed understanding of the relationship between epigenetic regulation and ferroptosis in CVDs is lacking.
  • This review summarizes key mechanisms, highlighting epigenetic regulation of ferroptosis in CVDs.
  • Understanding these pathways may lead to novel therapeutic strategies targeting ferroptosis in cardiovascular conditions.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.0K